PUBLISHED DATE : Mar 2020 | Pages : 245
Fill out your details & get your free sample
Cardiac Assist Devices Market Size, Share, & Trends Analysis Report by Application (Bridge To Transplant, Destination Therapy, and Others), Products (Intra-Aortic Balloon Pump, Ventricular Assist Devices, and Total Artificial Heart), End-Users (Hospitals and Special Cardiac Centers), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Global Analysis Report, Global Outlook, Market Trends, Competitive Landscape, Share, Growth Potential & Forecast, 2020-2025
245 Pages
35 Tables
103 Charts
5 Regions
17 Countries
14 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 2.4 BILLION (2025) |
| CAGR | 9% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Application (Bridge To Transplant, Destination Therapy, and Others), Products (Intra-Aortic Balloon Pump, Ventricular Assist Devices, and Total Artificial Heart), End-Users (Hospitals and Special Cardiac Centers) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Germany, France, UK, Spain, Italy, Japan, China, Australia, South Korea, India, Brazil, Mexico, Argentina, Turkey, and Saudi Arabia |
The cardiac assist devices market size to reach USD 2.4 billion by 2025, growing at a CAGR of 9% during the forecast period. The global market is expected to grow at a significant pace during the forecast period due to growing technological advancements, new product approvals, increasing elderly population, and improvements in reimbursement policies for heart failure.
The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage. For instance, Abbott received the USFDA approval for its HeartMate 3 LVAD, which can be used for long-term circulatory support and as destination therapy in patients who are not eligible for heart transplantations.
The cardiac assist devices have evolved into an appropriate treatment option for patients with advanced heart failure. With growing technological advancements, cardiac assist devices have become popular across the globe, especially in developed countries such as the US, Germany, France, Spain, Japan, the UK, and Australia.
This research report includes detailed segmentation by
The cardiac assist devices market is segmented into the bridge to transplantation (BTT), destination therapy (DT), and other applications. BTT accounted for a 53% share in the global cardiac assist devices market. The bridge to candidacy (BTC) segment is expected to grow steadily due to advances in technology. The destination therapy (DT) segment is expected to grow at the fastest CAGR of 12% on account of the shortage of heart donors, increasing prevalence of end-stage heart failures, and the availability of effective therapies to treat heart failures. The demand for DT is likely to increase as it supports long-term cardiac function in end-stage heart failure patients, who are ineligible for heart transplantation.
The VADs product segment is growing at a significant rate and is likely to grow at a similar pace during the forecast period. The market is expected to reach USD 2.2 billion in 2025, growing at a CAGR of 10% during the forecast period. The LVADs market segment accounted for 82% of the global cardiac assist devices market. The usage of LVAD, like a heart pump, has significantly improved the survival rate of patients who are waiting for heart transplantation. LVADs are also evolving rapidly as its accessibility is increasing across the globe among the developed and few developing countries than transplantation.
Intra-aortic balloon pumps (IABP) are considered to be the first line of treatment, especially in low and middle-income countries, and help treat the patient at critical stages. The segment is expected to grow due to several surgeons recommending IABP for treating advanced heart failures.
The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings. Patients prefer undergoing advanced heart failure treatment in hospitals due to their convenient locations and ease of accessibility. Moreover, the aging population and shortage of heart donors are other major factors likely to drive the segment growth.
Specialty cardiac centers (SSCs) are solely dedicated to treating patients suffering from several cardiovascular diseases. The segment is expected to grow at the fastest CAGR due to the availability of sophisticated infrastructure related to the diagnosis and high-quality treatment of CVDs in standalone cardiology centers. This segment is likely to grow at a faster rate and increase its market share to 42% by 2025.
The North American market heart transplant market is the major revenue-contributor and is expected to grow at the fastest CAGR of 11% due to favorable patient demographics, availability of skilled surgeons, and favorable reimbursement coverage. The increasing prevalence of obesity and diabetes, coupled with the aging population, has increased heart failures, which are expected to bolster the market.
Europe is the second-largest cardiac assist devices market and accounted for a share of 22% of the global market. In Europe, the market is likely to grow because of the increasing geriatric population with heart diseases and high awareness of the advantages of cardiac assist devices. Further, increased government investments for such devices are likely to boost industry growth. Germany, the UK, and France are the key countries in the region as they invest the highest in R&D activities than other European countries.
The APAC market is expected to grow at a moderate rate due to the increased healthcare expenditure, coupled with a high prevalence of CVDs. The market is likely to reach $246 million in 2025, growing at a CAGR of 6% during the forecast period. Japan, China, Australia, South Korea, and India are the major revenue contributors to the cardiac assist devices market in the APAC region.
The global cardiac assist device market is highly consolidated with major players accounting for a significant share of the industry. Abbott, Medtronic, SynCardia, Getinge, and Abiomed are identified as the leading vendors in the market. However, there are considerable growth opportunities for new entrants. Several investigational and small med-tech companies are expected to offer innovative products and technologies. The leading players are focusing on implementing several strategies such as product launches and approvals, acquisitions, and an increase in R&D investment to enhance their market share. Leading players are likely to dominate the industry on account of their strong presence and surgeons’ endorsement for their products due to the availability of abundant clinical data and efficacy.
Segmentation by Application
By Product
By End-user
By Geography
Frequently Asked Questions
What is the cardiac assist devices market size and growth forecast?
The cardiac assist devices market size to reach revenues of USD 2.4 billion, growing at a CAGR of over 9% during 2019-2025.
What are the factors impacting the growth of the cardiac assist devices market?
The cardiac assist devices market is expected to observe significant growth on account of the growing incidence of congestive heart failures worldwide, especially in the geriatric population.
Who are the key players in the cardiac assist devices market
The leading players in the cardiac assist devices market include Abbott and Medtronic.
Which segment is fueling the cardiac assist devices market growth?
The hospital segment is expected to dominate the market during the forecast period, as the number of hospitals offering cardiac care is relatively high than in other healthcare settings.
What are the recent technological advancements in cardiac assist devices?
The emergence of next-generation cardiac assist devices is expected to fuel industry growth during the forecast period. The industry has witnessed the launch of several advanced and innovative heart assist devices with major changes in product designs and material usage.
The following factors are likely to contribute to the growth of the cardiac assist devices market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the cardiac assist devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Vendors
Market Segmentation by Application
Market Segmentation by Product
Market Segmentation by End-user
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusion
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.4 Market Segmentation
4.4.1 Product
4.4.2 Application
4.4.3 End-users
4.4.4 Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Background
7.1.2 Cardiac Assist Devices
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Growing Global Prevalence/Incidence of Heart Failure
8.1.2 Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation
8.1.3 Growing Demand for Shared Care Centers & their Importance Post-LVAD
8.2 Market Restraints
8.2.1 High Cost of Cardiac Assist Devices
8.2.2 Stringent & Time-consuming Regulatory Approvals
8.2.3 Complications & Risks Associated with Cardiac Assist Devices
8.3 Market Opportunities and Trends
8.3.1 Technological Advancements
8.3.2 Promising Investigational Cardiac Assist Devices
8.3.3 New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices
9 Market Landscape
9.1 Market Overview
9.2 Market Size and Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Cardiac Assist Devices Market by Product
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
11 Ventricular Assist Devices
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.2.1 Market Size & Forecast
11.3 Ventricular Assist Devices Market Segmentation by Product
11.4 Left-Ventricular Assist Devices
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Other Ventricular Assist Devices
11.5.1 Market Overview
11.5.2 Market Size & Forecast
12 Intra-Aortic Balloon Pump Therapy Devices
12.1 Market Overview
12.2 Market Size & Forecast
13 Total Artificial Heart
13.1 Market Overview
13.2 Market Size & Forecast
14 Cardiac Assist Devices Market by Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Bridge to Transplantation (BTT)
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Destination Therapy (DT)
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Other Applications
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 Cardiac Assist Devices Market by End-Users
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Specialty Cardiac Centers
15.4.1 Market Overview
15.4.2 Market Size & Forecast
16 Cardiac Assist Devices Market by Geography
16.1 Market Snapshot & Growth Engine
16.2 Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 US: Cardiac Assist Devices Market Size & Forecast
17.3.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Germany: Cardiac Assist Devices Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 UK: Market Size & Forecast
18.3.4 Spain: Market Size & Forecast
18.3.5 Italy: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Japan: Cardiac Assist Devices Market Size & Forecast
19.3.2 China: Market Size & Forecast
19.3.3 Australia: Market Size & Forecast
19.3.4 South Korea: Market Size & Forecast
19.3.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Cardiac Assist Devices Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast
21 Middle East and Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.2 Key Countries
21.2.1 Turkey: Cardiac Assist Devices Market Size & Forecast
21.2.2 Saudi Arabia: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Analysis
22.2.1 Ventricular Assist Devices
22.2.2 IABP
22.2.3 Total Artificial Heart
23 Key Company Profiles
23.1 Abbott
23.1.1 Business Overview
23.1.2 Abbott in Global Cardiac Assist Devices Market
23.1.3 Major Product Offerings
23.1.4 Key Strengths
23.1.5 Key Strategies
23.1.6 Key Opportunities
23.2 Medtronic
23.2.1 Business Overview
23.2.2 Medtronic in Global Cardiac Assist Devices Market
23.2.3 Major Product Offerings
23.2.4 Key Strengths
23.2.5 Key Strategies
23.2.6 Key Opportunities
24 Other Prominent Vendors
24.1 Abiomed
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strengths
24.1.4 Key Strategies
24.1.5 Key Opportunities
24.2 Berlin Heart
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strengths
24.2.4 Key Strategies
24.2.5 Key Opportunities
24.3 Getinge
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strengths
24.3.4 Key Strategies
24.3.5 Key Opportunities
24.4 Syncardia
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strengths
24.4.4 Key Strategies
24.4.5 Key Opportunities
24.5 Teleflex
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strengths
24.5.4 Key Strategies
24.5.5 Key Opportunities
24.6 Zeon Medical
24.6.1 Business Overview
24.6.2 Product Offerings
24.6.3 Key Strengths
24.6.4 Key Strategies
24.6.5 Key Opportunities
24.7 Tokai Medical Products
24.7.1 Business Overview
24.7.2 Product Offerings
24.7.3 Key Strengths
24.7.4 Key Strategies
24.7.5 Key Opportunities
24.8 SENKO Medical Instrument
24.8.1 Business Overview
24.8.2 Product Offerings
24.8.3 Key Strengths
24.8.4 Key Strategies
24.8.5 Key Opportunities
24.9 Insightra Medical
24.9.1 Business Overview
24.9.2 Product Offerings
24.9.3 Key Strengths
24.9.4 Key Strategies
24.9.5 Key Opportunities
24.10 Reliantheart
24.10.1 Business Overview
24.10.2 Product Offerings
24.10.3 Key Strengths
24.10.4 Key Strategies
24.10.5 Key Opportunities
24.11 Pulsecath
24.11.1 Business Overview
24.11.2 Product Offerings
24.11.3 Key Strengths
24.11.4 Key Strategies
24.11.5 Key Opportunities
24.12 Jarvik Heart
24.12.1 Business Overview
24.12.2 Product Offerings
24.12.3 Key Strengths
24.12.4 Key Strategies
24.12.5 Key Opportunities
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
25.3 Quantitative Summary
25.3.1 Product
25.3.2 Application
25.3.3 End-users
25.3.4 Geography
26 Appendix
26.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Cardiac Assist Devices Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Various Treatment Options for Heart Failure
Exhibit 4 Impact of Growing Global Prevalence/Incidence of Heart Failure
Exhibit 5 Global Prevalence of Heart Failure in Adults
Exhibit 6 Prevalence of Heart Failure in Selected Countries 2017
Exhibit 7 Impact of Shortage of Donor Hearts & Increasing Patient Waiting List for Heart Transplantation
Exhibit 8 Heart Transplantation Waiting List in Key Countries/Regions 2017
Exhibit 9 Number of Heart Transplantations Performed in 2017
Exhibit 10 Comparison of Number of Heart Transplantations Performed in India 1994-2014 Versus 2016-2017
Exhibit 11 Impact of Growing Demand for Shared Care Centers & their Importance Post-LVAD Implantation
Exhibit 12 Shared Care Model Framework
Exhibit 13 Impact of High Cost of Cardiac Assist Devices
Exhibit 14 Impact of Stringent & Time-consuming Regulatory Approvals
Exhibit 15 Impact of Complications & Risks Associated with Cardiac Assist Devices
Exhibit 16 Impact of Technological Advancements
Exhibit 17 First-generation Cardiac Assist Devices
Exhibit 18 Impact of Promising Investigational Cardiac Assist Devices
Exhibit 19 Impact of New Product Approvals and Line Extensions for Existing Commercial Cardiac Assist Devices
Exhibit 20 Global Cardiac Assist Devices Market 2019−2025 ($ million)
Exhibit 21 Five Force Analysis 2019
Exhibit 22 Incremental Growth by Product 2019 & 2025
Exhibit 23 Global Cardiac Assist Devices Market by Product
Exhibit 24 Global Market by Product 2019 & 2025 (%)
Exhibit 25 Global Market by Product: Incremental Growth
Exhibit 26 Global Market by Product: Absolute Growth
Exhibit 27 Incremental Growth by Product 2019 & 2025
Exhibit 28 Global Ventricular Assist Devices Market: Incremental Growth Versus Absolute Growth Comparison
Exhibit 29 Global Ventricular Market 2019−2025 ($ million)
Exhibit 30 Global Ventricular Market by Product
Exhibit 31 Global Ventricular Market by Product 2019 & 2025 (%)
Exhibit 32 Global Ventricular Market by Product 2019-2025 ($ million)
Exhibit 33 Global Ventricular Market by Product 2019-2025 (%)
Exhibit 34 Global LVADs Market 2019−2025 ($ million)
Exhibit 35 Global Other Ventricular Assist Devices Market 2019−2025 ($ million)
Exhibit 36 Global Intra-aortic Balloon Pump Therapy Devices Market: Incremental Growth Versus Absolute Growth Comparison
Exhibit 37 Global Intra-aortic Balloon Pump Therapy Devices Market 2019−2025 ($ million)
Exhibit 38 Global Total Artificial Heart Market: Incremental Growth Versus Absolute Growth Comparison
Exhibit 39 Global Total Artificial Heart Market 2019−2025 ($ million)
Exhibit 40 Incremental Growth by Application 2019 & 2025
Exhibit 41 Global Cardiac Assist Devices Market by Application
Exhibit 42 Global Market by Application 2019 & 2025 (%)
Exhibit 43 Global Market by Application: Incremental Growth
Exhibit 44 Global Market by Application: Absolute Growth
Exhibit 45 Global Market by Bridge to Transplant: Incremental Growth Versus Absolute Growth
Exhibit 46 Global Market by Bridge to Transplantation 2019−2025 ($ million)
Exhibit 47 Global Market by Destination Therapy: Incremental Growth Versus Absolute Growth
Exhibit 48 Global Market by Destination Therapy 2019−2025 ($ million)
Exhibit 49 Global Market by Other Applications: Incremental Growth Versus Absolute Growth Comparison
Exhibit 50 Global Market by Other Applications 2019−2025 ($ million)
Exhibit 51 Incremental Growth by End-users 2019 & 2025
Exhibit 52 Global Market by End-users
Exhibit 53 Global Market by End-users 2019 & 2025 (%)
Exhibit 54 Global Market by End-users: Incremental Growth
Exhibit 55 Global Market by End-users: Absolute Growth
Exhibit 56 Global Market by Hospitals: Incremental Growth Versus Absolute Growth Comparison
Exhibit 57 Global Market by Hospitals 2019−2025 ($ million)
Exhibit 58 Global Market by Specialty Cardiac Centers: Incremental Growth Versus Absolute Growth Comparison
Exhibit 59 Global Market by Specialty Cardiac Centers 2019−2025 ($ million)
Exhibit 60 Incremental Growth by Geography 2019 & 2025
Exhibit 61 Global Cardiac Assist Devices Market by Geography
Exhibit 62 Global Market by Geography 2019 & 2025 (%)
Exhibit 63 Global Market by Geography: Incremental Growth
Exhibit 64 Global Market by Geography: Incremental Growth
Exhibit 65 Cardiac Assist Devices Market in North America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 66 Market in North America 2019–2025 ($ million)
Exhibit 67 Incremental Growth in North America 2019 & 2025
Exhibit 68 Market in US 2019–2025 ($ million)
Exhibit 69 Market in Canada 2019–2025 ($ million)
Exhibit 70 Cardiac Assist Devices Market in Europe: Incremental Growth Versus Absolute Growth Comparison
Exhibit 71 Market in Europe 2019–2025 ($ million)
Exhibit 72 Incremental Growth in Europe 2019 & 2025
Exhibit 73 Market in Germany 2019–2025 ($ million)
Exhibit 74 Market in France 2019–2025 ($ million)
Exhibit 75 Market in UK 2019–2025 ($ million)
Exhibit 76 Market in Spain 2019–2025 ($ million)
Exhibit 77 Market in Italy 2019–2025 ($ million)
Exhibit 78 Cardiac Assist Devices Market in APAC: Incremental Growth Versus Absolute Growth Comparison
Exhibit 79 Market in APAC 2019–2025 ($ million)
Exhibit 80 Incremental Growth in APAC 2019 & 2025
Exhibit 81 Market in Japan 2019–2025 ($ million)
Exhibit 82 Market in China 2019–2025 ($ million)
Exhibit 83 Market in Australia 2019–2025 ($ million)
Exhibit 84 Market in South Korea 2019–2025 ($ million)
Exhibit 85 Market in India 2019–2025 ($ million)
Exhibit 86 Cardiac Assist Devices Market in Latin America: Incremental Versus Absolute Growth Comparison
Exhibit 87 Market in Latin America 2019–2025 ($ million)
Exhibit 88 Incremental Growth in Latin America 2019 & 2025
Exhibit 89 Market in Brazil 2019–2025 ($ million)
Exhibit 90 Market in Mexico 2019–2025 ($ million)
Exhibit 91 Market in Argentina 2019–2025 ($ million)
Exhibit 92 Cardiac Assist Devices Market in Middle East & Africa: Incremental Growth Versus Absolute Growth Comparison
Exhibit 93 Market in Middle East and Africa 2019–2025 ($ million)
Exhibit 94 Incremental Growth in Middle East and Africa 2019 & 2025
Exhibit 95 Market in Turkey 2019–2025 ($ million)
Exhibit 96 Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 97 Abbott: R&D Expenditure in FY2016, FY2017 and FY2018 ($ million)
Exhibit 98 Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)
Exhibit 99 Abbott Sales Breakdown by Geography 2018 (%)
Exhibit 100 Medtronic Sales Breakdown by Segments FY2018 (%)
Exhibit 101 Medtronic R&D Expenditure FY2016-FY2018 ($ million)
Exhibit 102 Medtronic Revenue Breakdown by Geography FY2018 (%)
Exhibit 103 Medtronic Revenue by Business Segments in FY2017 and FY2018 ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 New York Heart Association Classification of Heart Failure
Table 4 Potential Benefits of Shared Care Model for Various Stakeholders
Table 5 Cost of Various Cardiac Assist Devices
Table 6 Complications Related to Cardiac Assist Devices & Their Prevalence
Table 7 Popular First, Second, and Third-generation Cardiac Assist Devices
Table 8 List of Promising Investigational Cardiac Assist Devices
Table 9 List of Cardiac Assist Devices Approved/Launched in Various Countries
Table 10 List of Cardiac Assist Devices Approved for New Indications
Table 11 Global Ventricular Assist Market: Vendors Ranking
Table 12 Global Ventricular Assist Market: Vendors Ranking
Table 13 Abbott Group: Product Offerings
Table 14 Medtronic: Major Clinical Trials for Heart Failure Treatment
Table 15 Medtronic: Product Offerings
Table 16 Abiomed: Key Product Offerings
Table 17 Berlin Heart: Key Product Offerings
Table 18 Getinge: Key Product Offerings
Table 19 SynCardia: Key Product Offerings
Table 20 Teleflex: Key Product Offerings
Table 21 ZEON MEDICAL: Key Product Offerings
Table 22 Tokai Medical Products: Key Product Offerings
Table 23 SENKO MEDICAL INSTRUMENT: Key Product Offerings
Table 24 Insightra Medical: Key Product Offerings
Table 25 ReliantHeart: Key Product Offerings
Table 26 PulseCath: Key Product Offerings
Table 27 Jarvik Heart: Key Product Offerings
Table 28 Global Cardiac Assist Devices Market by Product ($ million)
Table 29 Global Market by Product (%)
Table 30 Global Market by Application ($ million)
Table 31 Global Market by Application (%)
Table 32 Global Market by End-users ($ million)
Table 33 Global Market by End-users (%)
Table 34 Global Market by Geography ($ million)
Table 35 Global Market by Geography (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
